The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
Judge Blocks Class Status in Major Commission Lawsuit, Shaking Up the Real Estate Industry
A federal judge has denied class‑certification in the high‑stakes Batton commission lawsuit, delivering a temporary win for NAR and major brokerages while leaving the door open for plaintiffs to try again. With as much as $3.6 billion in potential damages on the line and nearly 80% of the proposed class now disqualified due to conflicts with earlier settlements, the case stands at a pivotal moment. Real estate professionals nationwide — especially in Florida — should watch closely, as the ruling could shape the future of buyer‑agent compensation.
